Coronavirus Drug Discovery
Volume 1: SARS-CoV-2 (COVID-19) Prevention, Diagnosis, and Treatment
- 1st Edition - May 25, 2022
- Latest edition
- Editor: Chukwuebuka Egbuna
- Language: English
Coronavirus Drug Discovery, Volume 1: SARS-CoV-2 (COVID-19) Prevention, Diagnosis, and Treatment is the first of three volumes presenting comprehensive information on drug di… Read more
World Book Day celebration
Where learning shapes lives
Up to 25% off trusted resources that support research, study, and discovery.
Description
Description
Coronavirus Drug Discovery, Volume 1: SARS-CoV-2 (COVID-19) Prevention, Diagnosis, and Treatment is the first of three volumes presenting comprehensive information on drug discovery against COVID-19. This volume provides background information on the genesis of COVID-19, the epidemiology, transmission, pathogenesis, and mutagenesis. It also presents the various treatment options, drug discovery opportunities and vaccine developmental processes. Written by global team of experts from key institutions across the globe, this book is recommended to all concerned agencies, private research firms, and consortiums working on finding a solution to COVID-19 and its variants. By design, this book will be useful to drug developers, medicinal chemists, pharmacologists, health experts, researchers, students and faculty members in industry and academia.
Key features
Key features
- Presents information on the genesis of COVID-19, global impact and collaborative efforts
- Details the epidemiology, transmission, pathogenesis, and mutagenesis of SARS-CoV-2
- Documents the various treatment options and vaccine development for COVID-19
Readership
Readership
Researchers in organic and medicinal chemistry including drug developers, medicinal chemists, toxicologists, analytical chemists. Researchers in pharmaceutical and biotech industries
Table of contents
Table of contents
Product details
Product details
- Edition: 1
- Latest edition
- Published: May 27, 2022
- Language: English
About the editor
About the editor
CE
Chukwuebuka Egbuna
Chukwuebuka Egbuna (PhD) is a chartered chemist and academic researcher. He is a member of the Institute of Chartered Chemists of Nigeria (ICCON), the Nigerian Society of Biochemistry and Molecular Biology (NSBMB), and the Royal Society of Chemistry (RSC) (United Kingdom). Dr. Egbuna is the founder and editor of the Elsevier book series on Drug Discovery Update. The series includes books, monographs, and edited collections from all areas of drug discovery including emerging therapeutic claims for the treatment of diseases. He has published research articles in many international journals of repute and is ranked among the top 500 Nigerian scientists in SciVal/SCOPUS. He has edited more than 25 books with Elsevier, Springer, Wiley, and Taylor & Francis. His most recent book is the three volume Coronavirus Drug Discovery, published by Elsevier. Dr. Egbuna is the founder and the publishing director of IPS Intelligentsia Publishing Services.